SCHEMBL16619441

SCHEMBL16619441

Cc1nnc2ccc(CCC(C)(C)C)cn12

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.33
SCN5A Q14524 1/20 0.31
BRD4 O60885 2/20 0.30
CCNC P24863 1/20 0.30
CDK8 P49336 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15028546 0.78 BRD4 (0.33) HRH3BRD4CCNCCDK8
SCHEMBL17616515 0.70 SCN5A (0.47) HRH3SCN5ABRD4CCNCCDK8
SCHEMBL16629892 0.67 HTR2C (0.39) BRD4CCNCCDK8
SCHEMBL20160365 0.66 SMN1; SMN2 (0.35) HRH3SCN5ABRD4CCNCCDK8
SCHEMBL16686865 0.66 PIM1 (0.38) HRH3BRD4CCNCCDK8
SCHEMBL12510429 0.66 SCN5A (0.42) SCN5A
SCHEMBL12510331 0.66 CCNC (0.45) BRD4CCNCCDK8
SCHEMBL16619439 0.66 CCNC (0.40) HRH3SCN5ACCNCCDK8
SCHEMBL11158794 0.66 SCN5A (0.66) HRH3SCN5A
SCHEMBL21076151 0.64 CYP1A2 (0.52) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052099-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS Merck Sharp & Dohme Corp. (US) 2016-08-10 EP disclosed
WO-2015050798-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2015-04-09 WO disclosed